Effects of bone marrow‑derived mesenchymal stem cells transplanted via the portal vein or tail vein on liver injury in rats with liver cirrhosis

Song,Ying‑Ming; Lian,Chang‑Hong; Wu,Cheng‑Song; Ji,Ai‑Fang; Xiang,Juan‑Juan; Wang,Xiao‑Yan

doi:10.3892/etm.2015.2232

Effects of bone marrow‑derived mesenchymal stem cells transplanted via the portal vein or tail vein on liver injury in rats with liver cirrhosis

Authors:
- Ying‑Ming Song
- Chang‑Hong Lian
- Cheng‑Song Wu
- Ai‑Fang Ji
- Juan‑Juan Xiang
- Xiao‑Yan Wang
View Affiliations

Affiliations: Department of General Surgery, Heping Hospital, Changzhi Medical College, Changzhi, Shanxi 046000, P.R. China, Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China, Cancer Research Institute, Central South University, Changsha, Hunan 410078, P.R. China
Published online on: January 29, 2015 https://doi.org/10.3892/etm.2015.2232
Pages: 1292-1298

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to compare the effects of bone marrow‑derived mesenchymal stem cells (BMSCs) transplanted via the portal vein or tail vein on liver injury in rats with liver cirrhosis. BMSCs were isolated from rat bone marrow and labeled with green fluorescent protein (GFP). Then, the labeled BMSCs were injected into rats with liver injury via the portal vein or tail vein. Two weeks after transplantation, three rats in each group were sacrificed to test the distribution of GFP in the liver and the serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and albumin. Six weeks later, the remaining rats were sacrificed, and serum ALT, AST, albumin, hyaluronic acid (HA), laminin (LN) and procollagen type III (PC‑III) levels were measured. The expression of albumin in the liver was analyzed by immunohistochemistry. Two weeks after BMSC transplantation, GFP‑positive cells were detected in the livers of rats with BMSCs transplanted via the portal vein and tail vein. Compared with pre‑transplantation levels, the ALT levels of the groups with BMSC transplantation via the portal vein and tail vein were significantly decreased after two and six weeks of BMSC transplantation (P<0.05), whereas the AST and albumin levels were not significantly different at two weeks after BMSC transplantation in the two groups (all P>0.05). However, the AST and albumin levels were significantly reduced at six weeks after BMSC transplantation (all P<0.05). At six weeks after BMSC transplantation, the serum HA, LN and PC‑III levels in rats transplanted with BMSCs via the portal vein or tail vein had decreased significantly (all P<0.05), as compared with the levels prior to BMSC transplantation. BMSCs transplanted via the portal vein and tail vein achieved similar improvements in liver function in rats with liver cirrhosis, which suggests that peripheral venous administration is a convenient and effective route for BMSC transplantation.

View Figures

View References

1	Manns MP: Liver cirrhosis, transplantation and organ shortage. Dtsch Arztebl Int. 110:83–84. 2013.PubMed/NCBI
2	Margini C, Vukotic P, Brodosi L, et al: Bone marrow derived stem cells for the treatment of end-stage liver disease. World J Gastroenterol. 21:9098–9105. 2014.
3	Yuan S, Jiang T, Zheng R, et al: Effect of bone marrow mesenchymal stem cell transplantation on acute hepatic failure in rats. Exp Ther Med. 8:1150–1158. 2014.PubMed/NCBI
4	Sun L, Fan X, Zhang L, et al: Bone mesenchymal stem cell transplantation via four routes for the treatment of acute liver failure in rats. Int J Mol Med. 34:987–996. 2014.PubMed/NCBI
5	Lau GK, Suri D, Liang R, et al: Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology. 122:614–624. 2002. View Article : Google Scholar : PubMed/NCBI
6	Di Campli C, Piscaglia AC, Giuliante S, et al: No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure. Transplant Proc. 97:2563–2566. 2005. View Article : Google Scholar
7	Gaia S, Smedile A, Omedè P, et al: Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol. 45:13–19. 2006. View Article : Google Scholar : PubMed/NCBI
8	Liang L, Ma T, Chen W, et al: Therapeutic potential and related signal pathway of adipose-derived stem cell transplantation for rat liver injury. Hepatol Res. 39:822–832. 2009. View Article : Google Scholar : PubMed/NCBI
9	Gasbarrini A, Rapaccini GL, Rutella S, et al: Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. Dig Liver Dis. 39:878–882. 2007. View Article : Google Scholar
10	Jin SZ, Han MZ and Qu B: Advances in stem cell transplantation for liver injury. Shi Jie Hua Ren Xiao Hua Za Zhi. 15:3320–3323. 2007.(In Chinese).
11	Xiang J, Tang J, Song C, et al: Mesenchymal stem cells as a gene therapy carrier for treatment of fibrosarcoma. Cytotherapy. 11:516–526. 2009. View Article : Google Scholar : PubMed/NCBI
12	Wu N, Zhou DF, Qi JL, et al: Effect of ligustrazine on the expression of bFGF in bone marrow stromal cells of mice after BMT. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 14:1004–1007. 2006.(In Chinese). PubMed/NCBI
13	Li XH, Fu YH, Liu ZY, et al: Efficacy comparison between transplanting microenvironmental induced and non-induced bone marrow mesenchymal stem cells in ischemic rat hearts. Zhonghua Xin Xue Guan Bing Za Zhi. 37:680–684. 2009.(In Chinese). PubMed/NCBI
14	Li T, Zhu J, Ma K, et al: Autologous bone marrow-derived mesenchymal stem cell transplantation promotes liver regeneration after portal vein embolization in cirrhotic rats. J Surg Res. 184:1161–73. 2013. View Article : Google Scholar : PubMed/NCBI
15	Longo DL: Chapter 308 Cirrhosis and Its Complications. Harrison’s principles of internal medicine. 18th ed. McGraw-Hill; New York: pp. 394–399. 2012
16	Sellamuthu S, Manikandan R, Thiagarajan R, et al: In vitro trans-differentiation of human umbilical cord derived hematopoietic stem cells into hepatocyte like cells using combination of growth factors for cell based therapy. Cytotechnolog. 63:259–268. 2011. View Article : Google Scholar
17	Yagi K, Kojima M, Oyagi S, et al: Application of mesenchymal stem cells to liver regenerative medicine. Yakugaku Zasshi. 128:3–9. 2008.(In Japanese). View Article : Google Scholar : PubMed/NCBI
18	Wang PP, Wang JH, Yan ZP, et al: Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF induction. Biochem Biophys Res Commun. 320:712–716. 2004. View Article : Google Scholar : PubMed/NCBI
19	Lin N, Lin J, Bo L, et al: Differentiation of bone marrow-derived mesenchymal BMSCs into hepatocyte-like cells in an alginate scaffold. Cell Prolif. 43:427–434. 2010. View Article : Google Scholar : PubMed/NCBI
20	Li J, Tao R, Wu W, et al: 3D PLGA scaffolds improve differentiation and function of bone marrow mesenchymal stem cell-derived hepatocytes. Stem Cells Dev. 19:1427–1436. 2010. View Article : Google Scholar : PubMed/NCBI
21	Pan XN, Shen JK, Zhuang YP, et al: Autologous bone marrow stem cell transplantation for treatment terminal liver diseases. Nan Fang Yi Ke Da Xue Xue Bao. 28:1207–1209. 2008.(In Chinese). PubMed/NCBI
22	Zhou B, Shan H, Li D, et al: MR tracking of magnetically labeled mesenchymal stem cell in rats with liver fibrosis. Magn Reson Imaging. 28:394–399. 2010. View Article : Google Scholar : PubMed/NCBI
23	Puglisi MA, Tesori V, Lattanzi W, et al: Therapeutic implications of mesenchymal stem cell in liver injury. J Biomed Biotechnol. 2011:8605782011. View Article : Google Scholar
24	Dalakas E, Newsome PN, Boyle S, et al: Bone marrow stem cell contribute to alcohol liver fibrosis in humans. Stem Cells Dev. 19:1417–1425. 2010. View Article : Google Scholar
25	Zheng JF and Liang LJ: Intra-portal transplantation of bone marrow stromal cells ameliorates liver fibrosis in mice. Hepatobiliary Pancreat Dis Int. 7:264–270. 2008.PubMed/NCBI
26	Shi L, Li G, Wang J, et al: Bone marrow stromal cells control the growth of hepatic stellate cells in vitro. Dig Dis Sci. 53:2969–2974. 2008. View Article : Google Scholar : PubMed/NCBI
27	Shi LJ, Li SX, Sun B, et al: Effects of bone marrow mesenchymal stem cells on the proliferation of hepatocytes and cirrhotic fat-storing cells in vitro. Zhonghua Gan Zang Bing Za Zhi. 15:681–684. 2007.(In Chinese). PubMed/NCBI